Explore HKAPI’s key moments: Policy forums, workshops, and stakeholder events driving healthcare access in Hong Kong and Macao.
2026
Mr Pan Jianhong from the Center for Drug Evaluation, National Medical Products Administration (NMPA), shared his perspectives on “Politics and Guidelines related to Real-World Research in the Chinese Mainland.”
Our sincere thanks to guest speakers and partners for making this forum possible.
Around 100 participants from the industry attended the event.
Ms Sabrina Chan, Senior Executive Director of HKAPI, delivers an opening remarks.
Participants had a fruitful discussion regarding the draft DH guidelines.
Regulatory Affairs Working Group members
Ms Linda Chan, Lead of the Regulatory Affairs Working Group, delivered an opening speech to kick start the event, and shared the industry’s proposal for data exclusivity in latter session.